Bayesian Capital Management’s STAAR Surgical STAA Stock Holding History

Bayesian Capital Management’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,784	Closed	-$552K	–	1005
2022 Q2	$552K	Buy	7,784 +5,215	+203%	+$336K	0.1%	304
2022 Q1	$205K	Buy	+2,569	New	+$191K	0.03%	644
2020 Q3	–	Sell	-4,200	Closed	-$258K	–	684
2020 Q2	$258K	Sell	4,200 -4,759	-53%	-$194K	0.06%	385
2020 Q1	$289K	Sell	8,959 -600	-6%	-$20.2K	0.06%	465
2019 Q4	$336K	Buy	+9,559	New	+$315K	0.06%	398
2019 Q1	–	Sell	-29,913	Closed	-$955K	–	736
2018 Q4	$955K	Buy	29,913 +13,000	+77%	+$507K	0.2%	167
2018 Q3	$812K	Buy	+16,913	New	+$692K	0.13%	219

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EFM

E Fund Management Guangzhou, China $3.37B AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Bayesian Capital Management's STAA Position: Q3 2022 in Review

Bayesian Capital Management sold out of STAAR Surgical (STAA) in Q3 2022, closing a stake of 7,784 shares — an estimated $552K sold.

Bayesian Capital Management first reported a position in STAA in Q3 2018 and held it in 7 quarters. The position peaked at $955K in Q4 2018. 304 funds tracked by Wall St. Rank hold STAA as of Q3 2022.

Bayesian Capital Management reported no remaining STAAR Surgical position as of Q3 2022 after selling out during the quarter.
Bayesian Capital Management sold 7,784 STAAR Surgical shares in Q3 2022, an estimated $552K.
Bayesian Capital Management first reported a position in STAAR Surgical in Q3 2018 and held it in 7 quarters.
Bayesian Capital Management's STAAR Surgical position peaked at $955K in Q4 2018.
304 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2022.

Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.